Jubilant Pharmova Limited (JUBLPHARMA)
₹1,072.3
INR+2.50(+0.23%)
As of December 27, 2024 9:59:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹16820.84 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹18856.96 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
28.43
Forward P/E
Price to Earnings ratio based on forecasted earnings
33.05
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.43
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
68.16%
Operating Margin
Operating income as a percentage of revenue
11.30%
Return on Equity
Net income as a percentage of shareholders' equity
10.40%
Revenue (TTM)
Total revenue over trailing 12 months
₹6919.70 Cr+4.3%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1116.50 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹37.34+64.5%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1077.40 Cr
Total Debt
Total short-term and long-term debt
₹3080.40 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
51.97%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹530.8 - ₹1309.9
Beta
Measure of stock's volatility compared to the market
1.56
Shares Outstanding
Total number of shares issued by the company
₹15.84 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
1.85%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
NA
Payout Ratio
Percentage of earnings paid as dividends
13.39%